MOJ Header

Current Issue - March 2025, Volume 19, Issue No. 1

Official Journal of Malaysian Orthopaedic Association and ASEAN Orthopaedic Association

Prevalence of Blood Transfusion and Factors Influencing Blood Loss Following Primary Total Knee Replacement Surgery

References

  1. Moran CG, Horton TC. Total knee replacement: the joint of the decade. A successful operation, for which there's a large unmet need. BMJ. 2000; 320 (7238): 820. doi: 10.1136/bmj.320.7238.820
  2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; 89(4): 780-5. doi: 10.2106/JBJS.F.00222
  3. Prasad N, Padmanabhan V, Mullaji A. Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop. 2007; 31(1): 39-44. doi: 10.1007/s00264-006-0096-9
  4. Vandenbussche E, Duranthon LD, Couturier M, Pidhorz L, Augereau B. The effect of tourniquet use in total knee arthroplasty. Int Orthop. 2002; 26(5): 306-9. doi: 10.1007/s00264-002-0360-6
  5. Kalairajah Y, Simpson D, Cossey AJ, Verrall GM, Spriggins AJ. Blood loss after total knee replacement: effects of computer-assisted surgery. J Bone Joint Surg Br. 2005; 87(11): 1480-2. doi: 10.1302/0301-620X.87B11.16474
  6. Li X, Qi XB, Han X, Wang W, Liu JN, Guo JC, et al. Effects of sealing the intramedullary femoral canal in total knee arthroplasty: A randomized study. Medicine (Baltimore). 2017; 96(29): e7388. doi: 10.1097/MD.0000000000007388
  7. Camarasa MA, Ollé G, Serra-Prat M, Martín A, Sánchez M, Ricós P, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006; 96(5): 576-82. doi: 10.1093/bja/ael057
  8. Parvizi J, Diaz-Ledezma C. Total knee replacement with the use of a tourniquet: more pros than cons. Bone Joint J. 2013; 95-B(11 Suppl A): 133-4. doi: 10.1302/0301-620X.95B11.32903
  9. Jiang FZ, Zhong HM, Hong YC, Zhao GF. Use of a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Orthop Sci. 2015; 20(1): 110-23. doi: 10.1007/s00776-014-0664-6
  10. Larson A, Hoitsma S, Metzger J, Oehlke K, Bebensee S. Impact of Tranexamic Acid on Blood Loss and Need for Blood Transfusions in Total Knee and Total Hip Arthroplasty. Fed Pract. 2017; 34(5): 14-9.
  11. Menendez ME, Lu N, Huybrechts KF, Ring D, Barnes CL, Ladha K, et al. Variation in Use of Blood Transfusion in Primary Total Hip and Knee Arthroplasties. J Arthroplasty. 2016; 31(12): 2757-63.e2. doi: 10.1016/j.arth.2016.05.022
  12. Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013; 95(19): 1777-83. doi: 10.2106/JBJS.L.01335
  13. Husain AS. Comparison of Blood Loss using Intra-Articular Injection of Tranexamic Acid after Total Knee Replacement. IMJM. 2020; 18(3). doi: 10.31436/imjm.v18i2.595
  14. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol. 2008; 21(5): 664-8. doi: 10.1097/ACO.0b013e32830f1fd1
  15. Bou Monsef J, Boettner F. Blood management may have an impact on length of stay after total hip arthroplasty. HSS J. 2014; 10(2): 124-30. doi: 10.1007/s11420-014-9384-x
  16. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014; 96(4): 272-8. doi: 10.2106/JBJS.L.01268
  17. Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am. 2014; 96(23): 1945-51. doi: 10.2106/JBJS.N.00077
  18. Saleh A, Small T, Chandran Pillai AL, Schiltz NK, Klika AK, Barsoum WK. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. J Bone Joint Surg Am. 2014; 96(18): e155. doi: 10.2106/JBJS.M.00825
  19. McVay PA, Toy PT. Very severe outcomes associated with autologous blood donation. Transfusion. 1996; 36(8): 761. doi: 10.1046/j.1537-2995.1996.36896374384.x
  20. Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg Br. 2012; 94(11 Suppl A): 8-10. doi: 10.1302/0301-620X.94B11.30618
  21. Krebs V, Hozack WJ, Callaghan JJ, Bohannon Mason J, Mont M, Parvizi J. Eliminating transfusion in primary joint arthroplasty-an achievable goal. J Arthroplasty. 2014; 29(8): 1511. doi: 10.1016/j.arth.2014.07.014
  22. Palmer A, Chen A, Matsumoto T, Murphy M, Price A. Blood management in total knee arthroplasty: state-of-the-art review. JISAKOS. 2018; 3: 358-66. doi:10.1136/jisakos-2017-000168
  23. Boutsiadis A, Reynolds RJ, Saffarini M, Panisset JC. Factors that influence blood loss and need for transfusion following total knee arthroplasty. Ann Transl Med. 2017; 5(21): 418. doi: 10.21037/atm.2017.08.11
  24. Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015; 10: 48. doi: 10.1186/s13018-015-0188-6
  25. Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010; 115(22): 4331-6. doi: 10.1182/blood-2010-01-251348
  26. Mohamud WN, Musa KI, Khir AS, Ismail AA, Ismail IS, Kadir KA, et al. Prevalence of overweight and obesity among adult Malaysians: an update. Asia Pac J Clin Nutr. 2011; 20(1): 35-41.
  27. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes (Lond). 2011; 35(2): 167-87. doi: 10.1038/ijo.2010.135
  28. Wan Nazaimoon WM, Md Isa SH, Wan Mohamad WB, Khir AS, Kamaruddin NA, Kamarul IM, et al. Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion. Diabet Med. 2013; 30(7): 825-8. doi: 10.1111/dme.12161
  29. Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007; 262(2): 157-72. doi: 10.1111/j.1365-2796.2007.01824.x
  30. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013; 35(2): 121-6. doi: 10.4103/0253-7176.116232
  31. National Blood Centre, Ministry of Health Malaysia. "Handbook on Clinical Use of Blood". https://pdn.gov.my/v2/images/dokumen/HANDBOOK_ON_CLINICAL_USE_OF_BLOOD_v2.021.10.2020.pdf
  32. Al-Turki AA, Al-Araifi AK, Badakhan BA, Al-Nazzawi MT, Alghnam S, Al-Turki AS. Predictors of blood transfusion following total knee replacement at a tertiary care center in Central Saudi Arabia. Saudi Med J. 2017; 38(6): 598-603. doi: 10.15537/smj.2017.6.17475
  33. Mufarrih SH, Qureshi NQ, Ali A, Malik AT, Naim H, Noordin S. Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the South Asian population. BMC Musculoskelet Disord. 2017; 18(1): 359. doi: 10.1186/s12891-017-1728-5
  34. Nichols CI, Vose JG. Comparative Risk of Transfusion and Incremental Total Hospitalization Cost for Primary Unilateral, Bilateral, and Revision Total Knee Arthroplasty Procedures. J Arthroplasty. 2016; 31(3): 583-9.e1. doi: 10.1016/j.arth.2015.10.013
  35. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000; 82(1): 89-100. doi: 10.2106/00004623-200001000-00011
  36. Rasouli MR, Maltenfort MG, Erkocak OF, Austin MS, Waters JH, Parvizi J. Blood management after total joint arthroplasty in the United States: 19-year trend analysis. Transfusion. 2016; 56(5): 1112-20. doi: 10.1111/trf.13518
  37. Bohm ER, Molodianovitsh K, Dragan A, Zhu N, Webster G, Masri B, et al. Outcomes of unilateral and bilateral total knee arthroplasty in 238,373 patients. Acta Orthop. 2016; 87 Suppl 1(Suppl 1): 24-30. doi: 10.1080/17453674.2016.1181817
  38. Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee. 2000; 7(3): 151-5. doi: 10.1016/s0968-0160(00)00047-8
  39. Cuenca J, García-Erce JA, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg. 2007; 5(2): 89-94. doi: 10.1016/j.ijsu.2006.02.003
  40. Song K, Pan P, Yao Y, Jiang T, Jiang Q. The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty. J Orthop Surg Res. 2019; 14(1): 273. doi: 10.1186/s13018-019-1329-0
  41. Zhang P, Liang Y, He J, Fang Y, Chen P, Wang J. Timing of tourniquet release in total knee arthroplasty: A meta-analysis. Medicine (Baltimore). 2017; 96(17): e6786. doi: 10.1097/MD.0000000000006786

Abstract   |   Reference

MOJ footer

About Us

The Malaysian Orthopaedic Journal is a peer-reviewed journal that is published three times a year in both print and electronic online version. The purpose of this journal is to publish original research studies, evaluation of current practices and case reports in various subspecialties of orthopaedics and traumatology, as well as associated fields like basic science, biomedical engineering, rehabilitation medicine and nursing.

Keep in Touch

creative-commons License